Keyphrases
Peptidomimetics
100%
Dopaminergic Neurotransmission
100%
6-hydroxydopamine (6-OHDA)
100%
Glycinamide
100%
Rotational Model
100%
Apomorphine
37%
Novel Analogues
37%
Tardive Dyskinesia
12%
Therapeutic Agents
12%
Striatum
12%
Dopamine Receptor
12%
Therapeutic Efficacy
12%
Octane
12%
Lesion Model
12%
Wistar Rats
12%
Rotational Motion
12%
Agonist Binding
12%
Limbic Regions
12%
Receptor Activity
12%
Rotational Response
12%
Inhibiting Factors
12%
Bell-shaped
12%
Dose-response Relationship
12%
Contralateral Rotations
12%
α-Melanocyte-stimulating Hormone (α-MSH)
12%
Carboxamide
12%
MIF-1
12%
Hormone Release
12%
Delivered Dose
12%
Modulatory Activity
12%
Apomorphine-induced Rotation
12%
Prolinamide
12%
Intrastriatal
12%
Unilateral Lesions
12%
Dopamine D2 Receptor Agonist
12%
Parkinsonian Symptoms
12%
Dioxo
12%
Medicine and Dentistry
Neurotransmission
100%
Peptidomimetic Agent
100%
Glycinamide
100%
Proline Derivative
100%
Oxidopamine
100%
Apomorphine
40%
Contralateral
20%
Combination Therapy
10%
Symptom
10%
Tardive Dyskinesia
10%
Therapeutic Agent
10%
Striatum
10%
Circling Behavior
10%
Carboxamide
10%
Dose Response
10%
Prolylleucylglycinamide
10%
Intrastriatal Drug Administration
10%
Octane
10%
Dopamine 2 Receptor Stimulating Agent
10%
Melanostatin
10%
Dopamine Receptor
10%
Pharmacology, Toxicology and Pharmaceutical Science
Dopamine Receptor Stimulating Agent
100%
Peptidomimetic Agent
100%
Glycinamide
100%
Proline Derivative
100%
Oxidopamine
100%
Apomorphine
40%
Dose-Response Relationship
10%
Wistar Rat
10%
Tardive Dyskinesia
10%
Symptom
10%
Octane
10%
Prolylleucylglycinamide
10%
Melanostatin
10%
Dopamine 2 Receptor Stimulating Agent
10%
Combination Therapy
10%
Carboxamide
10%
Dopamine Receptor
10%